Masonic Cancer Center, University of Minnesota

University of Minnesota Masonic Cancer Center Logo

Masonic Cancer Center of the University of Minnesota

Print this page. Mail this link to a friend.

Prevention and Etiology Research Program

The Masonic Cancer Center has a strong national reputation for its members' research on the causes and prevention of cancer. The goals of the scientists who are members of the Prevention and Etiology Research Program are to:

  • identify risk factors for cancer;
  • evaluate strategies for early detection;
  • develop and test approaches for cancer prevention; and
  • reduce untoward effects of living with cancer and improve quality of life for cancer survivors.

Using a mulitdisciplinary approach to accomplish these goals, the program brings together investigators from the University of Minnesota's School of Public Health, Medical School, College of Food, Agricultural and Natural Resource Sciences, Hormel Institute, and from the Minnesota Department of Health. The program's multidisciplinary projects include:

Center Grants

Studies in Recruitment

Pediatric Studies

Resources

Cohort Studies

Shared Resources

Scientists who are members of the Prevention and Etiology Research Program receive support from the Masonic Cancer Center's Shared Resources, including Biostatistics and Informatics and the Health Survey Research Center.

Program News

Carlin named head of Division of Biostatistics at the University of Minnesota School of Public Health

Ross receives Outstanding Faculty Mentor of Postdoctoral Scholars Award

Public Health Moment podcast: Tanning Beds and Skin Cancer Risk (School of Public Health)

Yuan awarded $3 million NCI grant for research to predict lung cancer risk

Ross, Poynter, Jurek awarded $100,000 NIH grants

University of Minnesota researchers find childhood cancer risk rises with mother's age

U of M researchers discover direct link between smoking and developing lung cancer in humans

U of M study shows eating burned meat increases risk of pancreatic cancer

U.S. cancer screening trial shows no mortality benefit through 10 years of study from annual prostate cancer screening